tracken
Viking Therapeutics, Inc. Aktie News
Positiv
The Motley Fool
●
etwa 19 Stunden alt
Viking Therapeutics develops therapies to treat obesity. Several of its drug candidates showed promising data during phase 2 trials.
Positiv
InvestorPlace
●
ein Tag alt
As we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused investors. Despite facing volatility and regulatory challenges in recent years, biotech is poised for a resurgence.
Positiv
The Motley Fool
●
2 Tage alt
Viking has multiple GLP-1 drugs in development that have been generating impressive results. Given this market's potential, its financials could improve dramatically if one of its drugs is approved.
Positiv
The Motley Fool
●
3 Tage alt
Viking Therapeutics is looking to make noise in a fast-growing therapeutic area. Recursion Pharmaceuticals' approach could change the way we develop drugs.
Positiv
InvestorPlace
●
4 Tage alt
Momentum trading is one of my favorite strategies. Legendary trader Mark Minervini, who won the U.S. investing championship in 1997 and 2021, used momentum trading strategies to win.
Positiv
The Motley Fool
●
5 Tage alt
Viking Therapeutics stock is up by a significant amount this year. It still has key catalysts on the way that investors should note.
Positiv
InvestorPlace
●
6 Tage alt
A lot of great stocks are flying under the radars of investors. There are plenty of lesser known stocks that are growing by leaps and bounds right now.
Positiv
InvestorPlace
●
7 Tage alt
The Russell 2000 is a stock market index comprised of 2,000 companies that have small market capitalizations. A small-cap stock is generally any security of a publicly traded company whose market value is between $250 million and $2 billion.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
